D.E. Shaw & Co
IMUX icon

D.E. Shaw & Co’s Immunic IMUX Stock Holding History

D.E. Shaw & Co’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,228
Closed -$69K – 4642
2024
Q1 		$69K Buy
+5,228
New +$67.9K ﹤0.01% 4032
2022
Q4 		– Sell
-5,698
Closed -$180K – 4971
2022
Q3 		$180K Buy
5,698
+629
+12% +$26.3K ﹤0.01% 4496
2022
Q2 		$176K Sell
5,069
-1,514
-23% -$97K ﹤0.01% 4590
2022
Q1 		$744K Buy
+6,583
New +$762K ﹤0.01% 4132
2018
Q3 		– Sell
-112
Closed -$308K – 3826
2018
Q2 		$308K Buy
112
+75
+203% +$173K ﹤0.01% 3360
2018
Q1 		$100K Sell
37
-89
-71% -$204K ﹤0.01% 3389
2017
Q4 		$301K Buy
126
+15
+14% +$33.2K ﹤0.01% 3243
2017
Q3 		$224K Buy
111
+4
+4% +$5.22K ﹤0.01% 3259
2017
Q2 		$125K Sell
107
-48
-31% -$64.1K ﹤0.01% 3248
2017
Q1 		$248K Sell
155
-11
-7% -$20.1K ﹤0.01% 3042
2016
Q4 		$288K Buy
166
+21
+14% +$46K ﹤0.01% 3132
2016
Q3 		$356K Buy
145
+28
+24% +$69.1K ﹤0.01% 2971
2016
Q2 		$289K Buy
117
+29
+33% +$95.3K ﹤0.01% 3031
2016
Q1 		$321K Buy
88
+41
+87% +$142K ﹤0.01% 2991
2015
Q4 		$215K Buy
+47
New +$153K ﹤0.01% 3526
2015
Q3 		– Sell
-204
Closed -$1.72M – 3797
2015
Q2 		$1.72M Buy
204
+15
+8% +$143K ﹤0.01% 2302
2015
Q1 		$1.89M Buy
189
+45
+31% +$414K ﹤0.01% 2053
2014
Q4 		$1.43M Buy
+144
New +$1.11M ﹤0.01% 2550

Other funds holding IMUX

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co's IMUX Position: Q2 2024 in Review

D.E. Shaw & Co sold out of Immunic (IMUX) in Q2 2024, closing a stake of 5,228 shares — an estimated $69K sold.

D.E. Shaw & Co first reported a position in IMUX in Q4 2014 and held it in 18 quarters. The position peaked at $1.89M in Q1 2015. 55 funds tracked by Wall St. Rank hold IMUX as of Q2 2024.

  • D.E. Shaw & Co reported no remaining Immunic position as of Q2 2024 after selling out during the quarter.
  • D.E. Shaw & Co sold 5,228 Immunic shares in Q2 2024, an estimated $69K.
  • D.E. Shaw & Co first reported a position in Immunic in Q4 2014 and held it in 18 quarters.
  • D.E. Shaw & Co's Immunic position peaked at $1.89M in Q1 2015.
  • 55 funds tracked by Wall St. Rank held Immunic as of Q2 2024.

Based on D.E. Shaw & Co's 13F filing for Q2 2024, filed 14 Aug 2024.